PERTUSSIS VACCINES

Clinical trials for PERTUSSIS VACCINES explained in plain language.

Never miss a new study

Get alerted when new PERTUSSIS VACCINES trials appear

Sign up with your email to follow new studies for PERTUSSIS VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New Low-Dose tdap vaccine trial aims to boost protection with fewer side effects

⭐️ VACCINE ⭐️ Not yet recruiting

This study tests a new version of the Tdap vaccine (which protects against tetanus, diphtheria, and whooping cough) that has reduced antigens. The goal is to see if it is safe and triggers a strong immune response in people aged 6 and up. Around 660 volunteers will receive either…

Matched conditions: PERTUSSIS VACCINES

Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 09:06 UTC

PERTUSSIS VACCINES

Get alerted when new PERTUSSIS VACCINES trials appear

New Low-Dose tdap vaccine trial aims to boost protection with fewer side effects